Angiopoietin-based interventions for treating cerebral malaria

The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin...

Full description

Saved in:
Bibliographic Details
Main Authors Purcell Ngambo Lisa Arleen, Higgins Sarah J, Kain Kevin C
Format Patent
LanguageChinese
English
Published 17.08.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1. 本发明提供用于治疗、预防脑型疟疾或降低其严重程度的方法。本发明的方法包括向有需要的受试者施用治疗有效量的包含诸如AngF1-Fc-F1的经修饰的血管生成素分子的药物组合物。
Bibliography:Application Number: CN201480058778